img

Global Hypogonadism Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

Published on: 2024-01-04 | No of Pages : 400 | Industry : Pharma & Healthcare

Publisher : MRA | Format : PDF

Global Hypogonadism Drug Market Report, History and Forecast 2018-2034, Breakdown Data by Manufacturers, Key Regions, Types and Application

There are two drugs for treatment of hypogonadism, one is testosterone replacement therapy drug; The other is used for gonadotropin treatment, which aims to maintain the normal development of male secondary sexual characteristics and restore fertility.
Hypogonadism Drug report published by Mr Accuracy reports reveals that COVID-19 and Russia-Ukraine War impacted the market dually in 2022. Global Hypogonadism Drug market is projected to reach US$ 4902.8 million in 2029, increasing from US$ 3393 million in 2022, with the CAGR of 5.4% during the period of 2024 to 2029. Demand from Hospital and Pharmacy are the major drivers for the industry.
Rising population and rising incidence and prevalence of chronic diseases such as diabetes and obesity drive the market growth. According to clinical studies, the testosterone levels of men aged 60-80 are 20% and 80% lower than those of young men, respectively. Hypogonadism is most common in men over the age of 60. In countries such as Japan, China, and the U.S., the demand for male hypogonadism treatment has surged due to rising geriatric population and surging infertility rates.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2024-2034), aims to help readers to get a comprehensive understanding of global Hypogonadism Drug market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
Manufacturers, Type, Application and Regions Listed in the Report



By Company


Allergan
AbbVie
Endo Pharmaceuticals
Pfizer Inc.
Clarus Therapeutics, Inc.
Aytu BioScience, Inc.
Antares Pharma
Upsher-Smith Laboratories, Inc.
Beijing Shuanghe Pharmaceutical Co., Ltd
Tianjin Jinyao Amino Acid Co., Ltd
Shanghai General Pharmaceutical Co., Ltd
Tianjin Lisheng Pharmaceutical Co., Ltd
Chengde Jiulong Pharmaceutical Co., Ltd
Harbin Pharmaceutical Group
Shenyang Keda Pharmaceutical Co., Ltd
Zhejiang Xianju Pharmaceutical Co., Ltd
Segment by Type
Injection
Capsule

Segment by Application


Hospital
Pharmacy
Specialist Clinic
Others

Segment by Region


North America
United States
Canada
Europe
Germany
France
U.K.
Italy
Russia
Asia-Pacific
China
Japan
South Korea
India
Australia
China Taiwan
Indonesia
Thailand
Malaysia
Latin America
Mexico
Brazil
Argentina
Middle East & Africa
Turkey
Saudi Arabia
UAE
Each chapter of the report provides detailed information for readers to understand the Hypogonadism Drug market further
Chapter 1Product Definition, Product Types, Volume and Revenue analysis of Each Type in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 2Manufacturer Competition Status, including Sales and Revenue comparison, Manufacturers’ commercial date of Hypogonadism Drug, product type offered by each manufacturer, Mergers & Acquisitions activities, Expansion activities occurred in the Hypogonadism Drug industry.
Chapter 3Historical (2018-2022) and forecast (2024-2034) volume and revenue analysis of Hypogonadism Drug in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa.
Chapter 4Product Application, Volume and Revenue analysis of Each Application in North America, Europe, Asia-Pacific, Latin America, Middle East and Africa from 2018 to 2024.
Chapter 5 to 9Country Level analysis of North America, Europe, Asia-Pacific, Latin America, Middle East and Africa, including volume and revenue analysis.
Chapter 10Manufacturers’ Outline, covering company’s basic information like headquarter, contact information, major business, Hypogonadism Drug introduction, etc. Hypogonadism Drug Sales, Revenue, Price and Gross Margin of each company as well as Recent Development are also contained in this part.
Chapter 11Industry Chain, like raw materials, manufacturing cost, are covered. In addition, market opportunities and challenges are emphasized as well in the chapter.
Chapter 12Market Channel, Distributors and Customers are listed.
Chapter 13Mr Accuracy reports’s Conclusions of Hypogonadism Drug market based on comprehensive survey.
Chapter 14Methodology and Data Sources adopted by Mr Accuracy reports.

Table of Content

1 Hypogonadism Drug Market Overview
1.1 Hypogonadism Drug Product Overview
1.2 Hypogonadism Drug Market Segment by Type
1.2.1 Injection
1.2.2 Capsule
1.3 Global Hypogonadism Drug Market Size by Type
1.3.1 Global Hypogonadism Drug Market Size Overview by Type (2018-2029)
1.3.2 Global Hypogonadism Drug Historic Market Size Review by Type (2018-2024)
1.3.3 Global Hypogonadism Drug Forecasted Market Size by Type (2024-2029)
1.4 Key Regions Market Size Segment by Type
1.4.1 North America Hypogonadism Drug Sales Breakdown by Type (2018-2024)
1.4.2 Europe Hypogonadism Drug Sales Breakdown by Type (2018-2024)
1.4.3 Asia-Pacific Hypogonadism Drug Sales Breakdown by Type (2018-2024)
1.4.4 Latin America Hypogonadism Drug Sales Breakdown by Type (2018-2024)
1.4.5 Middle East and Africa Hypogonadism Drug Sales Breakdown by Type (2018-2024)
2 Global Hypogonadism Drug Market Competition by Company
2.1 Global Top Players by Hypogonadism Drug Sales (2018-2024)
2.2 Global Top Players by Hypogonadism Drug Revenue (2018-2024)
2.3 Global Top Players by Hypogonadism Drug Price (2018-2024)
2.4 Global Top Manufacturers Hypogonadism Drug Manufacturing Base Distribution, Sales Area, Product Type
2.5 Hypogonadism Drug Market Competitive Situation and Trends
2.5.1 Hypogonadism Drug Market Concentration Rate (2018-2024)
2.5.2 Global 5 and 10 Largest Manufacturers by Hypogonadism Drug Sales and Revenue in 2022
2.6 Global Top Manufacturers by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hypogonadism Drug as of 2022)
2.7 Date of Key Manufacturers Enter into Hypogonadism Drug Market
2.8 Key Manufacturers Hypogonadism Drug Product Offered
2.9 Mergers & Acquisitions, Expansion
3 Hypogonadism Drug Status and Outlook by Region
3.1 Global Hypogonadism Drug Market Size and CAGR by Region: 2018 VS 2022 VS 2029
3.2 Global Hypogonadism Drug Historic Market Size by Region
3.2.1 Global Hypogonadism Drug Sales in Volume by Region (2018-2024)
3.2.2 Global Hypogonadism Drug Sales in Value by Region (2018-2024)
3.2.3 Global Hypogonadism Drug Sales (Volume & Value) Price and Gross Margin (2018-2024)
3.3 Global Hypogonadism Drug Forecasted Market Size by Region
3.3.1 Global Hypogonadism Drug Sales in Volume by Region (2024-2029)
3.3.2 Global Hypogonadism Drug Sales in Value by Region (2024-2029)
3.3.3 Global Hypogonadism Drug Sales (Volume & Value), Price and Gross Margin (2024-2029)
4 Global Hypogonadism Drug by Application
4.1 Hypogonadism Drug Market Segment by Application
4.1.1 Hospital
4.1.2 Pharmacy
4.1.3 Specialist Clinic
4.1.4 Others
4.2 Global Hypogonadism Drug Market Size by Application
4.2.1 Global Hypogonadism Drug Market Size Overview by Application (2018-2029)
4.2.2 Global Hypogonadism Drug Historic Market Size Review by Application (2018-2024)
4.2.3 Global Hypogonadism Drug Forecasted Market Size by Application (2024-2029)
4.3 Key Regions Market Size Segment by Application
4.3.1 North America Hypogonadism Drug Sales Breakdown by Application (2018-2024)
4.3.2 Europe Hypogonadism Drug Sales Breakdown by Application (2018-2024)
4.3.3 Asia-Pacific Hypogonadism Drug Sales Breakdown by Application (2018-2024)
4.3.4 Latin America Hypogonadism Drug Sales Breakdown by Application (2018-2024)
4.3.5 Middle East and Africa Hypogonadism Drug Sales Breakdown by Application (2018-2024)
5 North America Hypogonadism Drug by Country
5.1 North America Hypogonadism Drug Historic Market Size by Country
5.1.1 North America Hypogonadism Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
5.1.2 North America Hypogonadism Drug Sales in Volume by Country (2018-2024)
5.1.3 North America Hypogonadism Drug Sales in Value by Country (2018-2024)
5.2 North America Hypogonadism Drug Forecasted Market Size by Country
5.2.1 North America Hypogonadism Drug Sales in Volume by Country (2024-2029)
5.2.2 North America Hypogonadism Drug Sales in Value by Country (2024-2029)
6 Europe Hypogonadism Drug by Country
6.1 Europe Hypogonadism Drug Historic Market Size by Country
6.1.1 Europe Hypogonadism Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
6.1.2 Europe Hypogonadism Drug Sales in Volume by Country (2018-2024)
6.1.3 Europe Hypogonadism Drug Sales in Value by Country (2018-2024)
6.2 Europe Hypogonadism Drug Forecasted Market Size by Country
6.2.1 Europe Hypogonadism Drug Sales in Volume by Country (2024-2029)
6.2.2 Europe Hypogonadism Drug Sales in Value by Country (2024-2029)
7 Asia-Pacific Hypogonadism Drug by Region
7.1 Asia-Pacific Hypogonadism Drug Historic Market Size by Region
7.1.1 Asia-Pacific Hypogonadism Drug Market Size Growth Rate (CAGR) by Region: 2018 VS 2022 VS 2029
7.1.2 Asia-Pacific Hypogonadism Drug Sales in Volume by Region (2018-2024)
7.1.3 Asia-Pacific Hypogonadism Drug Sales in Value by Region (2018-2024)
7.2 Asia-Pacific Hypogonadism Drug Forecasted Market Size by Region
7.2.1 Asia-Pacific Hypogonadism Drug Sales in Volume by Region (2024-2029)
7.2.2 Asia-Pacific Hypogonadism Drug Sales in Value by Region (2024-2029)
8 Latin America Hypogonadism Drug by Country
8.1 Latin America Hypogonadism Drug Historic Market Size by Country
8.1.1 Latin America Hypogonadism Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
8.1.2 Latin America Hypogonadism Drug Sales in Volume by Country (2018-2024)
8.1.3 Latin America Hypogonadism Drug Sales in Value by Country (2018-2024)
8.2 Latin America Hypogonadism Drug Forecasted Market Size by Country
8.2.1 Latin America Hypogonadism Drug Sales in Volume by Country (2024-2029)
8.2.2 Latin America Hypogonadism Drug Sales in Value by Country (2024-2029)
9 Middle East and Africa Hypogonadism Drug by Country
9.1 Middle East and Africa Hypogonadism Drug Historic Market Size by Country
9.1.1 Middle East and Africa Hypogonadism Drug Market Size Growth Rate (CAGR) by Country: 2018 VS 2022 VS 2029
9.1.2 Middle East and Africa Hypogonadism Drug Sales in Volume by Country (2018-2024)
9.1.3 Middle East and Africa Hypogonadism Drug Sales in Value by Country (2018-2024)
9.2 Middle East and Africa Hypogonadism Drug Forecasted Market Size by Country
9.2.1 Middle East and Africa Hypogonadism Drug Sales in Volume by Country (2024-2029)
9.2.2 Middle East and Africa Hypogonadism Drug Sales in Value by Country (2024-2029)
10 Company Profiles
10.1 Allergan
10.1.1 Allergan Company Information
10.1.2 Allergan Introduction and Business Overview
10.1.3 Allergan Hypogonadism Drug Sales, Revenue and Gross Margin (2018-2024)
10.1.4 Allergan Hypogonadism Drug Products Offered
10.1.5 Allergan Recent Development
10.2 AbbVie
10.2.1 AbbVie Company Information
10.2.2 AbbVie Introduction and Business Overview
10.2.3 AbbVie Hypogonadism Drug Sales, Revenue and Gross Margin (2018-2024)
10.2.4 AbbVie Hypogonadism Drug Products Offered
10.2.5 AbbVie Recent Development
10.3 Endo Pharmaceuticals
10.3.1 Endo Pharmaceuticals Company Information
10.3.2 Endo Pharmaceuticals Introduction and Business Overview
10.3.3 Endo Pharmaceuticals Hypogonadism Drug Sales, Revenue and Gross Margin (2018-2024)
10.3.4 Endo Pharmaceuticals Hypogonadism Drug Products Offered
10.3.5 Endo Pharmaceuticals Recent Development
10.4 Pfizer Inc.
10.4.1 Pfizer Inc. Company Information
10.4.2 Pfizer Inc. Introduction and Business Overview
10.4.3 Pfizer Inc. Hypogonadism Drug Sales, Revenue and Gross Margin (2018-2024)
10.4.4 Pfizer Inc. Hypogonadism Drug Products Offered
10.4.5 Pfizer Inc. Recent Development
10.5 Clarus Therapeutics, Inc.
10.5.1 Clarus Therapeutics, Inc. Company Information
10.5.2 Clarus Therapeutics, Inc. Introduction and Business Overview
10.5.3 Clarus Therapeutics, Inc. Hypogonadism Drug Sales, Revenue and Gross Margin (2018-2024)
10.5.4 Clarus Therapeutics, Inc. Hypogonadism Drug Products Offered
10.5.5 Clarus Therapeutics, Inc. Recent Development
10.6 Aytu BioScience, Inc.
10.6.1 Aytu BioScience, Inc. Company Information
10.6.2 Aytu BioScience, Inc. Introduction and Business Overview
10.6.3 Aytu BioScience, Inc. Hypogonadism Drug Sales, Revenue and Gross Margin (2018-2024)
10.6.4 Aytu BioScience, Inc. Hypogonadism Drug Products Offered
10.6.5 Aytu BioScience, Inc. Recent Development
10.7 Antares Pharma
10.7.1 Antares Pharma Company Information
10.7.2 Antares Pharma Introduction and Business Overview
10.7.3 Antares Pharma Hypogonadism Drug Sales, Revenue and Gross Margin (2018-2024)
10.7.4 Antares Pharma Hypogonadism Drug Products Offered
10.7.5 Antares Pharma Recent Development
10.8 Upsher-Smith Laboratories, Inc.
10.8.1 Upsher-Smith Laboratories, Inc. Company Information
10.8.2 Upsher-Smith Laboratories, Inc. Introduction and Business Overview
10.8.3 Upsher-Smith Laboratories, Inc. Hypogonadism Drug Sales, Revenue and Gross Margin (2018-2024)
10.8.4 Upsher-Smith Laboratories, Inc. Hypogonadism Drug Products Offered
10.8.5 Upsher-Smith Laboratories, Inc. Recent Development
10.9 Beijing Shuanghe Pharmaceutical Co., Ltd
10.9.1 Beijing Shuanghe Pharmaceutical Co., Ltd Company Information
10.9.2 Beijing Shuanghe Pharmaceutical Co., Ltd Introduction and Business Overview
10.9.3 Beijing Shuanghe Pharmaceutical Co., Ltd Hypogonadism Drug Sales, Revenue and Gross Margin (2018-2024)
10.9.4 Beijing Shuanghe Pharmaceutical Co., Ltd Hypogonadism Drug Products Offered
10.9.5 Beijing Shuanghe Pharmaceutical Co., Ltd Recent Development
10.10 Tianjin Jinyao Amino Acid Co., Ltd
10.10.1 Tianjin Jinyao Amino Acid Co., Ltd Company Information
10.10.2 Tianjin Jinyao Amino Acid Co., Ltd Introduction and Business Overview
10.10.3 Tianjin Jinyao Amino Acid Co., Ltd Hypogonadism Drug Sales, Revenue and Gross Margin (2018-2024)
10.10.4 Tianjin Jinyao Amino Acid Co., Ltd Hypogonadism Drug Products Offered
10.10.5 Tianjin Jinyao Amino Acid Co., Ltd Recent Development
10.11 Shanghai General Pharmaceutical Co., Ltd
10.11.1 Shanghai General Pharmaceutical Co., Ltd Company Information
10.11.2 Shanghai General Pharmaceutical Co., Ltd Introduction and Business Overview
10.11.3 Shanghai General Pharmaceutical Co., Ltd Hypogonadism Drug Sales, Revenue and Gross Margin (2018-2024)
10.11.4 Shanghai General Pharmaceutical Co., Ltd Hypogonadism Drug Products Offered
10.11.5 Shanghai General Pharmaceutical Co., Ltd Recent Development
10.12 Tianjin Lisheng Pharmaceutical Co., Ltd
10.12.1 Tianjin Lisheng Pharmaceutical Co., Ltd Company Information
10.12.2 Tianjin Lisheng Pharmaceutical Co., Ltd Introduction and Business Overview
10.12.3 Tianjin Lisheng Pharmaceutical Co., Ltd Hypogonadism Drug Sales, Revenue and Gross Margin (2018-2024)
10.12.4 Tianjin Lisheng Pharmaceutical Co., Ltd Hypogonadism Drug Products Offered
10.12.5 Tianjin Lisheng Pharmaceutical Co., Ltd Recent Development
10.13 Chengde Jiulong Pharmaceutical Co., Ltd
10.13.1 Chengde Jiulong Pharmaceutical Co., Ltd Company Information
10.13.2 Chengde Jiulong Pharmaceutical Co., Ltd Introduction and Business Overview
10.13.3 Chengde Jiulong Pharmaceutical Co., Ltd Hypogonadism Drug Sales, Revenue and Gross Margin (2018-2024)
10.13.4 Chengde Jiulong Pharmaceutical Co., Ltd Hypogonadism Drug Products Offered
10.13.5 Chengde Jiulong Pharmaceutical Co., Ltd Recent Development
10.14 Harbin Pharmaceutical Group
10.14.1 Harbin Pharmaceutical Group Company Information
10.14.2 Harbin Pharmaceutical Group Introduction and Business Overview
10.14.3 Harbin Pharmaceutical Group Hypogonadism Drug Sales, Revenue and Gross Margin (2018-2024)
10.14.4 Harbin Pharmaceutical Group Hypogonadism Drug Products Offered
10.14.5 Harbin Pharmaceutical Group Recent Development
10.15 Shenyang Keda Pharmaceutical Co., Ltd
10.15.1 Shenyang Keda Pharmaceutical Co., Ltd Company Information
10.15.2 Shenyang Keda Pharmaceutical Co., Ltd Introduction and Business Overview
10.15.3 Shenyang Keda Pharmaceutical Co., Ltd Hypogonadism Drug Sales, Revenue and Gross Margin (2018-2024)
10.15.4 Shenyang Keda Pharmaceutical Co., Ltd Hypogonadism Drug Products Offered
10.15.5 Shenyang Keda Pharmaceutical Co., Ltd Recent Development
10.16 Zhejiang Xianju Pharmaceutical Co., Ltd
10.16.1 Zhejiang Xianju Pharmaceutical Co., Ltd Company Information
10.16.2 Zhejiang Xianju Pharmaceutical Co., Ltd Introduction and Business Overview
10.16.3 Zhejiang Xianju Pharmaceutical Co., Ltd Hypogonadism Drug Sales, Revenue and Gross Margin (2018-2024)
10.16.4 Zhejiang Xianju Pharmaceutical Co., Ltd Hypogonadism Drug Products Offered
10.16.5 Zhejiang Xianju Pharmaceutical Co., Ltd Recent Development
11 Upstream, Opportunities, Challenges, Risks and Influences Factors Analysis
11.1 Hypogonadism Drug Key Raw Materials
11.1.1 Key Raw Materials
11.1.2 Key Raw Materials Price
11.1.3 Raw Materials Key Suppliers
11.2 Manufacturing Cost Structure
11.2.1 Raw Materials
11.2.2 Labor Cost
11.2.3 Manufacturing Expenses
11.3 Hypogonadism Drug Industrial Chain Analysis
11.4 Hypogonadism Drug Market Dynamics
11.4.1 Hypogonadism Drug Industry Trends
11.4.2 Hypogonadism Drug Market Drivers
11.4.3 Hypogonadism Drug Market Challenges
11.4.4 Hypogonadism Drug Market Restraints
12 Market Strategy Analysis, Distributors
12.1 Sales Channel
12.2 Hypogonadism Drug Distributors
12.3 Hypogonadism Drug Downstream Customers
13 Research Findings and Conclusion
14 Appendix
14.1 Research Methodology
14.1.1 Methodology/Research Approach
14.1.2 Data Source
14.2 Author Details
14.3 Disclaimer

List of Figure

List of Tables
Table 1. Major Company of Injection
Table 2. Major Company of Capsule
Table 3. Global Hypogonadism Drug Sales by Type 2018 VS 2022 VS 2029 (US$ Million)
Table 4. Global Hypogonadism Drug Sales by Type (2018-2024) & (K Units)
Table 5. Global Hypogonadism Drug Sales Market Share in Volume by Type (2018-2024)
Table 6. Global Hypogonadism Drug Sales by Type (2018-2024) & (US& Million)
Table 7. Global Hypogonadism Drug Market Share in Value by Type (2018-2024)
Table 8. Global Hypogonadism Drug Price by Type (2018-2024) & (US$/Unit)
Table 9. Global Hypogonadism Drug Sales by Type (2024-2029) & (K Units)
Table 10. Global Hypogonadism Drug Sales Market Share in Volume by Type (2024-2029)
Table 11. Global Hypogonadism Drug Sales by Type (2024-2029) & (US$ Million)
Table 12. Global Hypogonadism Drug Sales Market Share in Value by Type (2024-2029)
Table 13. Global Hypogonadism Drug Price by Type (2024-2029) & (US$/Unit)
Table 14. North America Hypogonadism Drug Sales by Type (2018-2024) & (K Units)
Table 15. North America Hypogonadism Drug Sales by Type (2018-2024) & (US$ Million)
Table 16. Europe Hypogonadism Drug Sales (K Units) by Type (2018-2024)
Table 17. Europe Hypogonadism Drug Sales by Type (2018-2024) & (US$ Million)
Table 18. Asia-Pacific Hypogonadism Drug Sales (K Units) by Type (2018-2024)
Table 19. Asia-Pacific Hypogonadism Drug Sales by Type (2018-2024) & (US$ Million)
Table 20. Latin America Hypogonadism Drug Sales (K Units) by Type (2018-2024)
Table 21. Latin America Hypogonadism Drug Sales by Type (2018-2024) & (US$ Million)
Table 22. Middle East and Africa Hypogonadism Drug Sales (K Units) by Type (2018-2024)
Table 23. Middle East and Africa Hypogonadism Drug Sales by Type (2018-2024) & (US$ Million)
Table 24. Global Hypogonadism Drug Sales by Company (2018-2024) & (K Units)
Table 25. Global Hypogonadism Drug Sales Share by Company (2018-2024)
Table 26. Global Hypogonadism Drug Revenue by Company (2018-2024) & (US$ Million)
Table 27. Global Hypogonadism Drug Revenue Share by Company (2018-2024)
Table 28. Global Market Hypogonadism Drug Price by Company (2018-2024) & (US$/Unit)
Table 29. Global Hypogonadism Drug Top Manufacturers Manufacturing Base Distribution and Sales Area
Table 30. Global Hypogonadism Drug Manufacturers Market Concentration Ratio (CR5 and HHI)
Table 31. Global Top Manufacturers Market Share by Company Type (Tier 1, Tier 2 and Tier 3) & (based on the Revenue in Hypogonadism Drug as of 2022)
Table 32. Date of Key Manufacturers Enter into Hypogonadism Drug Market
Table 33. Key Manufacturers Hypogonadism Drug Product Type
Table 34. Mergers & Acquisitions, Expansion Plans
Table 35. Global Hypogonadism Drug Market Size Comparison by Region (US$ Million): 2018 VS 2022 VS 2029
Table 36. Global Hypogonadism Drug Sales by Region (2018-2024) & (K Units)
Table 37. Global Hypogonadism Drug Sales Market Share in Volume by Region (2018-2024)
Table 38. Global Hypogonadism Drug Sales by Region (2018-2024) & (US$ Million)
Table 39. Global Hypogonadism Drug Sales Market Share in Value by Region (2018-2024)
Table 40. Global Hypogonadism Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2018-2024)
Table 41. Global Hypogonadism Drug Sales by Region (2024-2029) & (K Units)
Table 42. Global Hypogonadism Drug Sales Market Share in Volume by Region (2024-2029)
Table 43. Global Hypogonadism Drug Sales by Region (2024-2029) & (US$ Million)
Table 44. Global Hypogonadism Drug Sales Market Share in Value by Region (2024-2029)
Table 45. Global Hypogonadism Drug Sales (K Units), Revenue (US$ Million), Price (US$/Unit) and Gross Margin (2024-2029)
Table 46. Global Hypogonadism Drug Sales by Application: 2018 VS 2022 VS 2029 (US$ Million)
Table 47. Global Hypogonadism Drug Sales by Application (2018-2024) & (K Units)
Table 48. Global Hypogonadism Drug Sales Market Share in Volume by Application (2018-2024)
Table 49. Global Hypogonadism Drug Sales by Application (2018-2024) & (US$ Million)
Table 50. Global Hypogonadism Drug Sales Market Share in Value by Application (2018-2024)
Table 51. Global Hypogonadism Drug Price by Application (2018-2024) & (US$/Unit)
Table 52. Global Hypogonadism Drug Sales by Application (2024-2029) & (K Units)
Table 53. Global Hypogonadism Drug Sales Market Share in Volume by Application (2024-2029)
Table 54. Global Hypogonadism Drug Sales by Application (2024-2029) & (US$ Million)
Table 55. Global Hypogonadism Drug Sales Market Share in Value by Application (2024-2029)
Table 56. Global Hypogonadism Drug Price by Application (2024-2029) & (US$/Unit)
Table 57. North America Hypogonadism Drug Sales by Application (2018-2024) (K Units)
Table 58. North America Hypogonadism Drug Sales by Application (2018-2024) & (US$ Million)
Table 59. Europe Hypogonadism Drug Sales by Application (2018-2024) (K Units)
Table 60. Europe Hypogonadism Drug Sales by Application (2018-2024) & (US$ Million)
Table 61. Asia-Pacific Hypogonadism Drug Sales by Application (2018-2024) (K Units)
Table 62. Asia-Pacific Hypogonadism Drug Sales by Application (2018-2024) & (US$ Million)
Table 63. Latin America Hypogonadism Drug Sales by Application (2018-2024) (K Units)
Table 64. Latin America Hypogonadism Drug Sales by Application (2018-2024) & (US$ Million)
Table 65. Middle East and Africa Hypogonadism Drug Sales by Application (2018-2024) (K Units)
Table 66. Middle East and Africa Hypogonadism Drug Sales by Application (2018-2024) & (US$ Million)
Table 67. North America Hypogonadism Drug Sales by Country (2018-2024) & (K Units)
Table 68. North America Hypogonadism Drug Sales Market Share in Volume by Country (2018-2024)
Table 69. North America Hypogonadism Drug Sales by Country (2018-2024) & (US$ Million)
Table 70. North America Hypogonadism Drug Sales Market Share in Value by Country (2018-2024)
Table 71. North America Hypogonadism Drug Sales by Country (2024-2029) & (K Units)
Table 72. North America Hypogonadism Drug Sales Market Share in Volume by Country (2024-2029)
Table 73. North America Hypogonadism Drug Sales by Country (2024-2029) & (US$ Million)
Table 74. North America Hypogonadism Drug Sales Market Share in Value by Country (2024-2029)
Table 75. Europe Hypogonadism Drug Sales by Country (2018-2024) & (K Units)
Table 76. Europe Hypogonadism Drug Sales Market Share in Volume by Country (2018-2024)
Table 77. Europe Hypogonadism Drug Sales by Country (2018-2024) & (US$ Million)
Table 78. Europe Hypogonadism Drug Sales Market Share in Value by Country (2018-2024)
Table 79. Europe Hypogonadism Drug Sales by Country (2024-2029) & (K Units)
Table 80. Europe Hypogonadism Drug Sales Market Share in Volume by Country (2024-2029)
Table 81. Europe Hypogonadism Drug Sales by Country (2024-2029) & (US$ Million)
Table 82. Europe Hypogonadism Drug Sales Market Share in Value by Country (2024-2029)
Table 83. Asia-Pacific Hypogonadism Drug Sales by Region (2018-2024) & (K Units)
Table 84. Asia-Pacific Hypogonadism Drug Sales Market Share in Volume by Region (2018-2024)
Table 85. Asia-Pacific Hypogonadism Drug Sales by Region (2018-2024) & (US$ Million)
Table 86. Asia-Pacific Hypogonadism Drug Sales Market Share in Value by Region (2018-2024)
Table 87. Asia-Pacific Hypogonadism Drug Sales by Region (2024-2029) & (K Units)
Table 88. Asia-Pacific Hypogonadism Drug Sales Market Share in Volume by Region (2024-2029)
Table 89. Asia-Pacific Hypogonadism Drug Sales by Region (2024-2029) & (US$ Million)
Table 90. Asia-Pacific Hypogonadism Drug Sales Market Share in Value by Region (2024-2029)
Table 91. Latin America Hypogonadism Drug Sales by Country (2018-2024) & (K Units)
Table 92. Latin America Hypogonadism Drug Sales Market Share in Volume by Country (2018-2024)
Table 93. Latin America Hypogonadism Drug Sales by Country (2018-2024) & (US$ Million)
Table 94. Latin America Hypogonadism Drug Sales Market Share in Value by Country (2018-2024)
Table 95. Latin America Hypogonadism Drug Sales by Country (2024-2029) & (K Units)
Table 96. Latin America Hypogonadism Drug Sales Market Share in Volume by Country (2024-2029)
Table 97. Latin America Hypogonadism Drug Sales by Country (2024-2029) & (US$ Million)
Table 98. Latin America Hypogonadism Drug Sales Market Share in Value by Country (2024-2029)
Table 99. Middle East and Africa Hypogonadism Drug Sales by Country (2018-2024) & (K Units)
Table 100. Middle East and Africa Hypogonadism Drug Sales Market Share in Volume by Country (2018-2024)
Table 101. Middle East and Africa Hypogonadism Drug Sales by Country (2018-2024) & (US$ Million)
Table 102. Middle East and Africa Hypogonadism Drug Sales Market Share in Value by Country (2018-2024)
Table 103. Middle East and Africa Hypogonadism Drug Sales by Country (2024-2029) & (K Units)
Table 104. Middle East and Africa Hypogonadism Drug Sales Market Share in Volume by Country (2024-2029)
Table 105. Middle East and Africa Hypogonadism Drug Sales by Country (2024-2029) & (US$ Million)
Table 106. Middle East and Africa Hypogonadism Drug Sales Market Share in Value by Country (2024-2029)
Table 107. Allergan Company Information
Table 108. Allergan Introduction and Business Overview
Table 109. Allergan Hypogonadism Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 110. Allergan Hypogonadism Drug Product
Table 111. Allergan Recent Development
Table 112. AbbVie Company Information
Table 113. AbbVie Introduction and Business Overview
Table 114. AbbVie Hypogonadism Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 115. AbbVie Hypogonadism Drug Product
Table 116. AbbVie Recent Development
Table 117. Endo Pharmaceuticals Company Information
Table 118. Endo Pharmaceuticals Introduction and Business Overview
Table 119. Endo Pharmaceuticals Hypogonadism Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 120. Endo Pharmaceuticals Hypogonadism Drug Product
Table 121. Endo Pharmaceuticals Recent Development
Table 122. Pfizer Inc. Company Information
Table 123. Pfizer Inc. Introduction and Business Overview
Table 124. Pfizer Inc. Hypogonadism Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 125. Pfizer Inc. Hypogonadism Drug Product
Table 126. Pfizer Inc. Recent Development
Table 127. Clarus Therapeutics, Inc. Company Information
Table 128. Clarus Therapeutics, Inc. Introduction and Business Overview
Table 129. Clarus Therapeutics, Inc. Hypogonadism Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 130. Clarus Therapeutics, Inc. Hypogonadism Drug Product
Table 131. Clarus Therapeutics, Inc. Recent Development
Table 132. Aytu BioScience, Inc. Company Information
Table 133. Aytu BioScience, Inc. Introduction and Business Overview
Table 134. Aytu BioScience, Inc. Hypogonadism Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 135. Aytu BioScience, Inc. Hypogonadism Drug Product
Table 136. Aytu BioScience, Inc. Recent Development
Table 137. Antares Pharma Company Information
Table 138. Antares Pharma Introduction and Business Overview
Table 139. Antares Pharma Hypogonadism Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 140. Antares Pharma Hypogonadism Drug Product
Table 141. Antares Pharma Recent Development
Table 142. Upsher-Smith Laboratories, Inc. Company Information
Table 143. Upsher-Smith Laboratories, Inc. Introduction and Business Overview
Table 144. Upsher-Smith Laboratories, Inc. Hypogonadism Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 145. Upsher-Smith Laboratories, Inc. Hypogonadism Drug Product
Table 146. Upsher-Smith Laboratories, Inc. Recent Development
Table 147. Beijing Shuanghe Pharmaceutical Co., Ltd Company Information
Table 148. Beijing Shuanghe Pharmaceutical Co., Ltd Introduction and Business Overview
Table 149. Beijing Shuanghe Pharmaceutical Co., Ltd Hypogonadism Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 150. Beijing Shuanghe Pharmaceutical Co., Ltd Hypogonadism Drug Product
Table 151. Beijing Shuanghe Pharmaceutical Co., Ltd Recent Development
Table 152. Tianjin Jinyao Amino Acid Co., Ltd Company Information
Table 153. Tianjin Jinyao Amino Acid Co., Ltd Introduction and Business Overview
Table 154. Tianjin Jinyao Amino Acid Co., Ltd Hypogonadism Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 155. Tianjin Jinyao Amino Acid Co., Ltd Hypogonadism Drug Product
Table 156. Tianjin Jinyao Amino Acid Co., Ltd Recent Development
Table 157. Shanghai General Pharmaceutical Co., Ltd Company Information
Table 158. Shanghai General Pharmaceutical Co., Ltd Introduction and Business Overview
Table 159. Shanghai General Pharmaceutical Co., Ltd Hypogonadism Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 160. Shanghai General Pharmaceutical Co., Ltd Hypogonadism Drug Product
Table 161. Shanghai General Pharmaceutical Co., Ltd Recent Development
Table 162. Tianjin Lisheng Pharmaceutical Co., Ltd Company Information
Table 163. Tianjin Lisheng Pharmaceutical Co., Ltd Introduction and Business Overview
Table 164. Tianjin Lisheng Pharmaceutical Co., Ltd Hypogonadism Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 165. Tianjin Lisheng Pharmaceutical Co., Ltd Hypogonadism Drug Product
Table 166. Tianjin Lisheng Pharmaceutical Co., Ltd Recent Development
Table 167. Chengde Jiulong Pharmaceutical Co., Ltd Company Information
Table 168. Chengde Jiulong Pharmaceutical Co., Ltd Introduction and Business Overview
Table 169. Chengde Jiulong Pharmaceutical Co., Ltd Hypogonadism Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 170. Chengde Jiulong Pharmaceutical Co., Ltd Hypogonadism Drug Product
Table 171. Chengde Jiulong Pharmaceutical Co., Ltd Recent Development
Table 172. Harbin Pharmaceutical Group Company Information
Table 173. Harbin Pharmaceutical Group Introduction and Business Overview
Table 174. Harbin Pharmaceutical Group Hypogonadism Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 175. Harbin Pharmaceutical Group Hypogonadism Drug Product
Table 176. Harbin Pharmaceutical Group Recent Development
Table 177. Shenyang Keda Pharmaceutical Co., Ltd Company Information
Table 178. Shenyang Keda Pharmaceutical Co., Ltd Introduction and Business Overview
Table 179. Shenyang Keda Pharmaceutical Co., Ltd Hypogonadism Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 180. Shenyang Keda Pharmaceutical Co., Ltd Hypogonadism Drug Product
Table 181. Shenyang Keda Pharmaceutical Co., Ltd Recent Development
Table 182. Zhejiang Xianju Pharmaceutical Co., Ltd Company Information
Table 183. Zhejiang Xianju Pharmaceutical Co., Ltd Introduction and Business Overview
Table 184. Zhejiang Xianju Pharmaceutical Co., Ltd Hypogonadism Drug Sales (K Units), Revenue (Million USD), Price (US$/Unit) and Gross Margin (2018-2024)
Table 185. Zhejiang Xianju Pharmaceutical Co., Ltd Hypogonadism Drug Product
Table 186. Zhejiang Xianju Pharmaceutical Co., Ltd Recent Development
Table 187. Key Raw Materials Lists
Table 188. Raw Materials Key Suppliers Lists
Table 189. Hypogonadism Drug Market Trends
Table 190. Hypogonadism Drug Market Drivers
Table 191. Hypogonadism Drug Market Challenges
Table 192. Hypogonadism Drug Market Restraints
Table 193. Hypogonadism Drug Distributors List
Table 194. Hypogonadism Drug Downstream Customers
Table 195. Research Programs/Design for This Report
Table 196. Key Data Information from Secondary Sources
Table 197. Key Data Information from Primary Sources
List of Figures
Figure 1. Hypogonadism Drug Product Picture
Figure 2. Global Hypogonadism Drug Market Size, 2018 VS 2022 VS 2029 (US$ Million)
Figure 3. Global Hypogonadism Drug Market Size Status and Outlook (2018-2029) & (US$ Million)
Figure 4. Global Hypogonadism Drug Sales Status and Outlook (2018-2029) & (K Units)
Figure 5. Product Picture of Injection
Figure 6. Global Injection Sales YoY Growth (2018-2029) & (K Units)
Figure 7. Product Picture of Capsule
Figure 8. Global Capsule Sales YoY Growth (2018-2029) & (K Units)
Figure 9. Global Hypogonadism Drug Sales by Type (2018-2029) & (US$ Million)
Figure 10. Global Hypogonadism Drug Sales Market Share by Type in 2022 & 2029
Figure 11. North America Hypogonadism Drug Sales Market Share in Volume by Type in 2022
Figure 12. North America Hypogonadism Drug Sales Market Share in Value by Type in 2022
Figure 13. Europe Hypogonadism Drug Sales Market Share in Volume by Type in 2022
Figure 14. Europe Hypogonadism Drug Sales Market Share in Value by Type in 2022
Figure 15. Asia-Pacific Hypogonadism Drug Sales Market Share in Volume by Type in 2022
Figure 16. Asia-Pacific Hypogonadism Drug Sales Market Share in Value by Type in 2022
Figure 17. Latin America Hypogonadism Drug Sales Market Share in Volume by Type in 2022
Figure 18. Latin America Hypogonadism Drug Sales Market Share in Value by Type in 2022
Figure 19. Middle East and Africa Hypogonadism Drug Sales Market Share in Volume by Type in 2022
Figure 20. Middle East and Africa Hypogonadism Drug Sales Market Share in Value by Type in 2022
Figure 21. The 5 and 10 Largest Manufacturers in the World: Market Share by Hypogonadism Drug Sales in 2022
Figure 22. The 5 and 10 Largest Manufacturers in the World: Market Share by Hypogonadism Drug Revenue in 2022
Figure 23. Hypogonadism Drug Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2018 VS 2022
Figure 24. Product Picture of Hospital
Figure 25. Global Hospital Sales YoY Growth (2018-2029) & (K Units)
Figure 26. Product Picture of Pharmacy
Figure 27. Global Pharmacy Sales YoY Growth (2018-2029) & (K Units)
Figure 28. Product Picture of Specialist Clinic
Figure 29. Global Specialist Clinic Sales YoY Growth (2018-2029) & (K Units)
Figure 30. Product Picture of Others
Figure 31. Global Others Sales YoY Growth (2018-2029) & (K Units)
Figure 32. Global Hypogonadism Drug Sales by Application (2018-2029) & (US$ Million)
Figure 33. Global Hypogonadism Drug Sales Market Share by Application in 2022 & 2029
Figure 34. North America Hypogonadism Drug Sales Market Share in Volume by Application in 2022
Figure 35. North America Hypogonadism Drug Sales Market Share in Value by Application in 2022
Figure 36. Europe Hypogonadism Drug Sales Market Share in Volume by Application in 2022
Figure 37. Europe Hypogonadism Drug Sales Market Share in Value by Application in 2022
Figure 38. Asia-Pacific Hypogonadism Drug Sales Market Share in Volume by Application in 2022
Figure 39. Asia-Pacific Hypogonadism Drug Sales Market Share in Value by Application in 2022
Figure 40. Latin America Hypogonadism Drug Sales Market Share in Volume by Application in 2022
Figure 41. Latin America Hypogonadism Drug Sales Market Share in Value by Application in 2022
Figure 42. Middle East and Africa Hypogonadism Drug Sales Market Share in Value by Application in 2022
Figure 43. Key Raw Materials Price
Figure 44. Hypogonadism Drug Manufacturing Cost Structure
Figure 45. Hypogonadism Drug Industrial Chain Analysis
Figure 46. Channels of Distribution
Figure 47. Distributors Profiles
Figure 48. Bottom-up and Top-down Approaches for This Report
Figure 49. Data Triangulation
Figure 50. Key Executives Interviewed

Select User License

$4200 Single Licence
$6000 Enterprise Licence
$9100 Corporate Licence
Note : All prices in USD

FAQ'S

User License?

For a single, multi and corporate client license, the report will be available in PDF format. Sample report would be given you in excel format. For more questions please contact:

sales@mraccuracyreports.com

Within 24 to 48 hrs.

You can contact Sales team (sales@mraccuracyreports.com) and they will direct you on email

You can order a report by selecting payment methods, which is bank wire or online payment through any Debit/Credit card, Razor pay or PayPal.

Discounts are available.

Hard Copy

Email

Top Industries